Madden Martin J. 4
4 · NovoCure Ltd · Filed Jun 6, 2024
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Madden Martin J.
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-05+6,229→ 6,229 totalExercise: $23.13Exp: 2034-06-04→ Ordinary Shares (6,229 underlying) - Award
Ordinary Shares
2024-06-05+4,053→ 19,673 total
Footnotes (3)
- [F1]These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2025 annual general meeting of shareholders.
- [F2]Report no longer includes indirect ownership of shares held by filer's adult child. Child no longer shares a residence with the filer.
- [F3]Options to buy 6,229 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2025 annual general meeting of shareholders.